Marie Roskrow

Marie Roskrow is an experienced physician-scientist and a senior executive with international experience in the healthcare and financial sectors. Her extensive experience includes early- and later-stage clinical development of novel anti-cancer compounds and the development of a novel therapeutic vaccine and complementary rapid diagnostic test for the treatment of patients with resistant Helicobacter pylori. She has held roles as CEO, CMO and Chairperson in private and listed companies, and has an extensive network of relationships with investors, senior executives and board members of healthcare companies and leading clinical centres both in Europe and the USA.